Status | Study |
Not yet recruiting |
Study Name: QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma Condition: Clear Cell Sarcoma Date: 2017-04-20 Interventions: Drug: AMG 337 6-{(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}- |
Recruiting |
Study Name: Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy Condition: Melanoma, Malignant, of Soft Parts Date: 2016-11-11 Interventions: Drug: Vemurafenib and Cobimetinib Combination of Vemurafenib with Cobimetinib in BRAF V600E/K mutated me |
Not yet recruiting |
Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Condition: Adrenal Cortex Carcinoma Adult Alveolar Soft Part Sarcoma Date: 2016-08-15 Interventions: Drug: Cabozantinib S-malate Gi |
Recruiting |
Study Name: Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors Condition: Retinoblastoma Clear Cell Sarcoma Date: 2015-02-24 Interventions: Drug: Simvastatin The starting |
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition: Adult Fibrosarcoma Alveolar Soft Part Sarcoma Angiomatoid Date: 2014-07-01 Interventions: Drug: Doxorubicin Hydrochloride |
Recruiting |
Study Name: Molecular-Guided Therapy for Childhood Cancer Condition: Neuroblastoma Medulloblastoma Glioma Date: 2014-06-11 Interventions: Device: Guided Therapy A total of 48 neuroblastoma, brain tumor, and rare tumor patients who are refract |
Completed |
Study Name: Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery Condition: Bone Cancer Chondrosarcoma Clear Cel Date: 2012-03-09 Interventions: Drug: therapeutic angiotensin-(1-7) |
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition: Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma Locally Advanced and/or Me Date: 2012-01-24 Interventions: Drug: Crizotinib (PF-02341066) For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of |
Active, not recruiting |
Study Name: Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors Condition: Ewing's Sarcoma Osteosarcoma Astrocytoma Date: 2011-04-06 Interventions: Drug: sirolimus daily administration of sirolimus in oral form starting at a dose of 1 mg/m2 and increas |
Recruiting |
Study Name: Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery Condition: Kidney Cancer Date: 2010-07-15 Interventions: Drug: gemcitabine hydrochloride |